Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine.
about
Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?Mouse models of polyglutamine diseases: review and data table. Part IRedox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Mutant huntingtin can paradoxically protect neurons from death.Killer proteases and little strokes--how the things that do not kill you make you stronger.Dysregulation of system xc(-) expression induced by mutant huntingtin in a striatal neuronal cell line and in R6/2 miceConstitutive upregulation of chaperone-mediated autophagy in Huntington's disease.Elevated dopamine levels during gestation produce region-specific decreases in neurogenesis and subtle deficits in neuronal numbers.The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies.The corticostriatal pathway in Huntington's disease.Impaired dopamine release and uptake in R6/1 Huntington's disease model miceIntrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice.Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene.Age-dependent biphasic changes in ischemic sensitivity in the striatum of Huntington's disease R6/2 transgenic mice.Proteomic analysis of protein expression and oxidative modification in r6/2 transgenic mice: a model of Huntington disease.RTP801 Is Involved in Mutant Huntingtin-Induced Cell Death.
P2860
Q26770781-D3C0CBB1-10A1-4EA8-B832-9922B9858C71Q26853025-719340FE-9E43-4C57-B3F1-CE4EA6DD8AFBQ30446460-B7F81936-96CF-4402-9BAF-D88EAEEC24A0Q33304630-769F84E4-02C9-4D15-B142-1A04DAE7AEB5Q33896931-405FC144-1F3D-4D03-AB61-8CAF41D3CC6AQ34293784-4D30FAA0-B3BA-46AB-AB41-6FFAF5ECDC02Q35767283-ED056FFC-BE33-4FEE-839B-07A2AF7003FCQ36276118-5C0FC11C-1C46-40E4-8253-FDEC04112B05Q36358871-D180A69F-B1E0-4A67-AE71-2490E8F138CFQ36684263-01299ED8-4429-45D2-B8A5-883AA2B8944EQ36916526-22B52E6F-A021-44A9-B3EE-59FD4AE0D28BQ37131550-422C18BE-4C47-4D5E-8EE9-BBA9978CEE13Q42513393-146F172E-D869-4AB9-8D2B-C1A8A0356ED1Q44405624-6E79BCAE-3E91-4135-B8BE-7695632661A9Q45297228-12E5E165-4EBD-4C5E-9143-C5CC8747F702Q48200890-38973D08-0171-4F74-8B62-ECCB4B336413
P2860
Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Mice transgenic for exon 1 of ...... opamine and 6-hydroxydopamine.
@en
Mice transgenic for exon 1 of ...... opamine and 6-hydroxydopamine.
@nl
type
label
Mice transgenic for exon 1 of ...... opamine and 6-hydroxydopamine.
@en
Mice transgenic for exon 1 of ...... opamine and 6-hydroxydopamine.
@nl
prefLabel
Mice transgenic for exon 1 of ...... opamine and 6-hydroxydopamine.
@en
Mice transgenic for exon 1 of ...... opamine and 6-hydroxydopamine.
@nl
P2093
P2860
P50
P921
P1476
Mice transgenic for exon 1 of ...... opamine and 6-hydroxydopamine.
@en
P2093
A Petersén
M DiFiglia
R F Castilho
Z Puschban
P2860
P304
P356
10.1046/J.0953-816X.2001.01765.X
P407
P577
2001-11-01T00:00:00Z